FAM
Fred Alger Management Portfolio holdings
AUM
$25.7B
1-Year Est. Return
82.9%
1 Year Est. Return
+82.9%
AUM
$25.7B
AUM Growth
+$3.35B
(+15%)
Holding
512
Top Buys
| 1 | +$401M | |
| 2 | +$285M | |
| 3 | +$182M | |
| 4 |
QXO
QXO Inc
QXO
|
+$173M |
| 5 |
MongoDB
MDB
|
+$162M |
Top Sells
| 1 | +$313M | |
| 2 | +$195M | |
| 3 | +$188M | |
| 4 |
Vistra
VST
|
+$148M |
| 5 |
GFL Environmental
GFL
|
+$118M |
Sector Composition
| 1 | Technology | 35.8% |
| 2 | Communication Services | 23.93% |
| 3 | Consumer Discretionary | 12.69% |
| 4 | Industrials | 8.99% |
| 5 | Healthcare | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Floor & Decor
FND
$6.84B
| $1.88M | 0.01% |
25,524
-3,050
|
|
||
327
United Therapeutics
UTHR
$21.1B
| $1.79M | 0.01% |
+4,262
|
|
||
328
Dianthus Therapeutics
DNTH
$1.9B
| $1.78M | 0.01% |
+45,304
|
|
||
329
Flex
FLEX
$23.1B
| $1.78M | 0.01% |
30,671
-800
|
|
||
330
Trevi Therapeutics
TRVI
$1.73B
| $1.75M | 0.01% |
191,045
+131,620
|
|
||
331
Equinix
EQIX
$72.8B
| $1.7M | 0.01% |
2,174
-31,117
|
|
||
332
Marvell Technology
MRVL
$83.9B
| $1.69M | 0.01% |
20,116
-490,637
|
|
||
333
Quest Diagnostics
DGX
$20.3B
| $1.67M | 0.01% |
8,757
-803
|
|
||
334
Abercrombie & Fitch
ANF
$4.35B
| $1.64M | 0.01% |
19,126
|
|
||
335
Vaxcyte
PCVX
$6.08B
| $1.64M | 0.01% |
45,414
+27,143
|
|
||
336
PAR Technology
PAR
$1.39B
| $1.58M | 0.01% |
39,951
-48,081
|
|
||
337
IBM
IBM
$288B
| $1.56M | 0.01% |
5,533
+3,880
|
|
||
338
HCA Healthcare
HCA
$111B
| $1.55M | 0.01% |
3,632
-238
|
|
||
339
Pure Storage
PSTG
$23.1B
| $1.55M | 0.01% |
18,462
+13,922
|
|
||
340
Costco
COST
$397B
| $1.54M | 0.01% |
1,662
-10,713
|
|
||
341
RTX Corp
RTX
$229B
| $1.41M | 0.01% |
8,398
-492
|
|
||
|
BCPC
342
Balchem Corp
BCPC
$4.87B
| $1.39M | 0.01% |
9,267
|
|
||
343
Procore
PCOR
$12.1B
| $1.37M | 0.01% |
18,801
-5,940
|
|
||
|
ONC
344
BeOne Medicines Ltd
ONC
$35.7B
| $1.31M | 0.01% |
+3,843
|
|
||
345
BioMarin Pharmaceuticals
BMRN
$10.3B
| $1.28M | 0.01% |
23,700
-4,907
|
|
||
346
Archer Aviation
ACHR
$6.31B
| $1.27M | ﹤0.01% |
+132,204
|
|
||
347
Mastercard
MA
$490B
| $1.25M | ﹤0.01% |
2,195
-161
|
|
||
348
Rhythm Pharmaceuticals
RYTM
$6.98B
| $1.25M | ﹤0.01% |
+12,335
|
|
||
349
Accenture
ACN
$165B
| $1.19M | ﹤0.01% |
4,823
-13,484
|
|
||
350
Vertex Pharmaceuticals
VRTX
$116B
| $1.19M | ﹤0.01% |
3,036
-3,137
|
|